Absentia Labs

Absentia Labs is building AI foundation models designed to predict how medicines behave inside the human body, with the ambition of helping transform biology from an experimental science into a more predictive one.

Its technology combines biological, chemical, and clinical data to model drug behaviour, predict safety and efficacy, and support faster decision-making throughout the drug development process.

By making human biology increasingly computable, Absentia Labs aims to help researchers develop safer medicines, reduce reliance on animal testing, and improve the speed and success of therapeutic innovation.

Founded in 2024 by Farhan Khodaee, Rohola Zandie and Robert Betancort, at the heart of Absentia Labs’ approach is the use of AI to create computational models of complex human biology.

These models are intended to provide greater insight into how potential medicines may behave before progressing further through the development pipeline. Absentia’s work builds the foundation models that will power the next generation of medicine, bringing together artificial intelligence and computational biology to address questions of drug safety and efficacy.

Its research includes an AI Predictive Drug-Induced Liver Injury module, part of the company’s work to model drug safety computationally.  More broadly, Absentia Labs is pursuing a future in which predictive biological models can complement conventional experimental approaches, potentially helping drug developers make better-informed decisions earlier in the discovery and development process.

In July 2026, JIMCO Life Sciences Fund participated in Absentia Labs’ seed funding round, supporting the company as it develops its AI-driven approach to predictive biology and its mission to remove the need for animals in clinical trials by replacing them with foundational AI models.

Through this investment, JIMCO is supporting a biotech startup working at the intersection of artificial intelligence, computational biology, and drug development, focused on creating new tools to understand human biology and enable the development of safer medicines.